Document is current
Any future updates will be listed below
-
Authors
Tseng, Chieh-En Jane http://orcid.org/0000-0003-0592-335X
Canales, Camila
Marcus, Rachel E.
Parmar, Anjali J.
Hightower, Baileigh G.
Mullett, Jennifer E.
Makary, Meena M.
Tassone, Alison U.
Saro, Hannah K.
Townsend, Paige Hickey
Birtwell, Kirstin
Nowinski, Lisa
Thom, Robyn P.
Palumbo, Michelle L.
Keary, Christopher
Catana, Ciprian http://orcid.org/0000-0002-3249-5971
McDougle, Christopher J.
Hooker, Jacob M. http://orcid.org/0000-0002-9394-7708
Zürcher, Nicole R. http://orcid.org/0000-0003-0271-6304
-
Funding
Funding for this research was provided by:
Robert E. and Donna Landreth Fund for the Study of Neuroimmune Interactions in Autism
- License Information
-
More Information
Article History
Received: 28 November 2023
Revised: 21 March 2024
Accepted: 2 April 2024
First Online: 13 April 2024
Competing interests
: RPT is an advisory board member of Targeted Education for Autism Across Medical Specialties, receives royalty payments from Oxford University Press and Springer Publishing, has received research support from Piton, and has received honoraria for speaking at the American Academy of Child and Adolescent Psychiatry Annual Meetings and the Neuroscience Education Institute. CK has served on paid scientific advisory committee for Biogen and Ionis. CJM is a paid consultant for Acadia Pharmaceuticals and Sage Therapeutics and receives royalty payments from Oxford University Press and Springer Publishing. JMH is editor-in-chief of ACS Chemical Neuroscience, a cofounder and equity holder in Eikonizo Therapeutics and Sensorium Therapeutics, a scientific advisory board member for Psy Therapeutics, Delix Therapeutics, Fuzionaire Diagnostics, Entheos Labs, Human and Rocket Science, and has received honoraria for speaking or advisory service at nonprofit academic institutions. All other authors report no potential conflicts of interest.
